Background Anxiety or depression symptoms may increase the risk of developing asthma, and their interaction with obesity is not known. We aimed to assess the association of anxiety or depression symptoms and the joint association of these symptoms and obesity with incident asthma.
Introduction
Asthma affects about 300 million people worldwide and represents approximately 1% of the total global disease burden. 1 There are also substantial social and economic burdens from asthma and its care. 1 The prevalence of doctor-diagnosed asthma in adults varies greatly between countries (e.g. 0.2% in China vs 21.0% in Australia) and is globally estimated to be 4.3%. 2 Asthma is a multifactorial condition and, historically, mental distress was thought to play a role in asthma pathogenesis. As far back as the 11th century, physicians warned that distress could cause asthma whereas joyfulness might have a beneficial effect. 3 The influence of emotional distress was seldom investigated in the first half of the 20th century, but this historical concept has gained support since recent studies suggested possible biological mechanisms. 4 Several studies on the association of anxiety or depression symptoms and asthma have been conducted. Cross-sectional studies have found that anxiety or depression symptoms are more prevalent in asthmatic patients, 5, 6 whereas others have observed that asthma patients were no more anxious or depressed than any other participants. 7 A limited number of prospective studies have investigated this association. 8, 9 Jonas and Wagener 8 found a moderate association of anxiety or depression symptoms with incident asthma in non-smoking adults. Scott et al. 9 found that early-onset anxiety and depression (at <21 years of age) had a moderate association with adult-onset asthma. Inflammation, irregular levels of circulating cortisol and glucocorticoid insensitivity may be underlying pathways of this association. [9] [10] [11] [12] Obesity has also been found to be associated with an increased risk of asthma in a number of prospective studies. 13, 14 One of the potential pathways for the obesity-asthma association is also via inflammation. 15 If anxiety or depression symptoms and obesity exacerbate a common pathway, we might expect to see a substantially elevated risk of asthma in people with both of these exposures. To our knowledge, the joint association of anxiety or depression symptoms and obesity with incident asthma has not yet been evaluated.
Therefore, we carried out a prospective cohort study of adults using the Nord-Trøndelag Health Study (HUNT) to: (i) investigate the association of anxiety or depression symptoms with incident asthma; and (ii) assess the joint association of anxiety or depression symptoms and obesity with incident asthma.
Methods

Study population
The study area was the county of Nord-Trøndelag (22 463 km 2 ), Norway. The adult population in Nord-Trøndelag (127 000 people in 1995) was invited to participate in three HUNT surveys which have been described elsewhere. 16 The population in Nord-Trøndelag is fairly representative of Norway with respect to age, income, morbidity and mortality. 17 The participants of this study took part in the second (HUNT 2, 1995-97) and third (HUNT 3, 2006-08) surveys of the HUNT, with an average 11 years of followup (n ¼ 37 071). 13, 17, 18 We studied 23 599 participants who were 19-55 years of age and free from asthma at baseline. The age limit was set as <65 years in HUNT 3 for two reasons: (i) to reduce misclassification of asthma and chronic obstructive pulmonary disease (COPD) 19 and (ii) obesity increases overall mortality. 20, 21 Senior participants with obesity are more likely to die compared with those without obesity, which can result in an under-estimation of the association of interest. Of the 23 599 participants, we excluded a further 353 (1.5%) with missing information on anxiety, depression or body mass index at baseline and on asthma both at baseline and followup, leaving 23 246 participants for the analysis.
Anxiety and depression symptoms
Anxiety and depression symptoms were measured with the Hospital Anxiety and Depression Scale (HADS). 22 The HADS consists of 14 questions of which seven measure anxiety symptoms and seven measure depression symptoms, during the past week. Each question is answered on a scale of 0-3, giving one total score for anxiety (HADS-A, range 0-21) and one total score for depression (HADS-D, range 0-21). A total score from 0 to 7 indicates normal state (normal), 8 to 10 indicates borderline anxiety or depression state (borderline) and 11-21 indicates caseness of anxiety or depression (caseness). 23 In the analysis stratified by obesity, we combined the last two categories (score [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] to define presence of symptoms (yes, no). Because of the coexistence of anxiety and depression, 24 we defined 'anxiety or depression symptoms' by the participants' highest score on either set of questions. Additional details of HADS are described elsewhere. 22 The HADS was used to describe the presence of symptoms and is not a psychiatric diagnosis.
Obesity
Body mass index (BMI) was used as a measure of obesity. Weight was measured to the nearest halfkilogram (kg) and height was measured to the nearest centimetre. BMI was calculated as weight divided by height squared (kg/m 2 ) and obesity was defined as BMI 530. 25 
Covariables
Covariables were collected from administrative questionnaires and clinical examinations at baseline. Covariables included age (19-29, 30-39, 40-49 , 50-55 years), sex, current smoking (yes, no, unknown), duration of physical activity (<1h, 1-2h, 53 h/week, unknown), family history of asthma (yes, no, unknown), years of education (<10, 10-12, 513 years, unknown), receiving social benefit (yes, no, unknown) and economic difficulties (yes, no, unknown). Family history of asthma was defined as a close family member (father, mother, brother or sister) with asthma. Social benefit was defined as those that reported receiving sick pay, rehabilitation benefits, retraining benefits, disability pension, old age pension, family income supplement, unemployment benefits, transitional benefits, widow's pension or any other benefit. Participants with economic difficulties were those who reported difficulties meeting the cost of food, transport and/or housing.
Asthma diagnosis
Asthma was defined by two approaches. 13, 18 In the first approach, asthma was defined by the survey question 'Do you have or have you had asthma?' Participants who reported 'no' to this question at baseline, and 'yes' at follow-up were classified as having incident asthma. In the second approach a stricter definition of asthma was used, i.e. no wheeze or asthma at baseline and reported asthma and use of asthma medication at follow-up, vs the reference group with no wheeze and no asthma at baseline or follow-up.
Statistical methods
In the analysis cohort of 23 246 participants, we evaluated anxiety or depression symptoms at baseline and cumulative incidence of asthma, in relation to other baseline characteristics. Pearson chi-square tests were used to evaluate differences between categories. To study the association of anxiety or depression symptoms with incident asthma, we estimated odds ratios (ORs) with 95% confidence intervals (CIs) using logistic regression.
In Model I, we adjusted for age, sex, smoking, physical activity, family history of asthma, education, social benefit and economic history at baseline as potential confounding factors. In Model II, we additionally adjusted for BMI as a continuous variable. We found no substantial difference in the associations of anxiety or depression with incident asthma between sexes (data not shown); subsequently we presented data in women and men combined. To test if the associations differed between sexes, we used a multiplicative model. The multiplicative model is commonly used to assess heterogeneity of association measures such as relative risks or odds ratios between subgroups. 26, 27 To assess the joint association of anxiety or depression symptoms and obesity with incident asthma, we generated four subgroups, i.e. non-obese participants without anxiety or depression symptoms (reference group), non-obese participants with anxiety or depression symptoms (OR A ), obese participants without anxiety or depression symptoms (OR B ) and obese participants with anxiety or depression symptoms (OR AB ). The joint association of anxiety or depression symptoms and obesity with incident asthma were estimated by using the relative excess risk due to interaction (RERI) with 95% CIs. The RERI was calculated using an additive model: RERI ¼ OR AB À OR A À OR B þ 1. 28 The additive model is used to test biological interaction between two or more risk factors that together assert their influence on disease risk. 27, 29 In brief, RERI 40 and the lower limit of 95% CI 40 suggests a synergistic effect of anxiety or depression and obesity on incident asthma. 28 To test the robustness of the associations, we repeated the main analysis using the second approach to define incident asthma (n ¼ 20 219). Further to this, we defined anxiety or depression symptoms as above, and additionally included those reporting use of antidepressant medication into the symptom group (n ¼ 20 219). Finally, we excluded participants who reported having or ever having had chronic bronchitis, emphysema or COPD in the follow-up questionnaires (n ¼ 20 048). We used STATA 12.0 for all statistical analyses (StataCorp LP, College Station, TX).
Ethics
The project was approved by the Regional Committee for Ethics in Medical Research. All participants signed informed consent for participation and the use of data in research.
Results
At baseline the total prevalences of anxiety and depression symptoms (HADS 58) were 15.0% and 7.8%, respectively ( Table 1 ). The prevalence of anxiety symptoms was higher in women than men, whereas for depression symptoms the pattern was opposite. The prevalence of anxiety and depression symptoms was higher in older participants, the obese and smokers, and those with low physical activity, a family history of asthma, social benefit and economic difficulties. The cumulative incidence of asthma during the 11-year follow-up was 3.8%. The cumulative incidence of asthma was higher in women, the obese and smokers, and those with less education, a family history of asthma, social benefit and economic difficulties. We found an association between anxiety or depression symptoms and incident asthma ( Table 2) . Participants with caseness anxiety or depression symptoms at baseline had a crude OR of 1.83 (95% CI 1.44-2.32) for incident asthma, compared with participants without these symptoms. After adjustment for possible confounders (Model I), the OR reduced to 1.39 (95% CI 1.09-1.78). Additional adjustment for BMI (Model II) did not change the estimates materially (Table 2) . A similar association was found in sex-specific analyses (data not shown). The P-value on the multiplicative scale to test heterogeneity between sexes was 0.53. Table 3 presents the estimates for the joint association of anxiety or depression symptoms and obesity with incident asthma. Compared with non-obese participants without anxiety or depression symptoms, the OR was 1.20 for non-obese participants with anxiety or depression symptoms and 1.47 for obese participants without anxiety or depression symptoms, whereas the OR increased to 2.93 (95% CI 2.20-3.91) for participants with both obesity and anxiety or depression symptoms ( Table 3 ). We found statistical evidence for a biological interaction beyond additivity for anxiety or depression symptoms and obesity at baseline and the risk of incident asthma, with RERI of 1.26 (95% CI 0.39-2.12). Figure 1 presents unadjusted cumulative incidence of asthma associated with the individual and joint exposures of anxiety or depression symptoms and obesity. We found a similar pattern in sex-specific analyses (data not shown). Using the second approach to define asthma, with a stricter definition, it yielded results similar to our main analyses ( Table 4 ). The OR for the participants with both obesity and anxiety or depression was 3.15 (95% CI 2.16-4.58), compared with non-obese participants without anxiety or depression. The relative excess risk for incident asthma due to interaction between anxiety or depression symptoms and obesity was 1.34 (95% CI 0.13-2.54). We observed similar associations when we included participants reporting Model I adjusted for age, sex, smoking, physical activity, family history of asthma, education, social benefit and economic difficulties at baseline. c Model II additionally adjusted for body mass index as a continuous variable. 
Discussion
In this large prospective study from the general population, adults reporting symptoms of anxiety or depression at baseline had an increased risk of incident asthma at follow-up. We also found that adults with anxiety or depression symptoms and obesity had a particularly increased risk of developing asthma. Our finding that anxiety or depression symptoms are moderately associated with incident asthma is supported by previous prospective studies. Chida et al. reviewed 34 studies of psychosocial factors on atopic disorders (91% were on asthma), and found a robust relationship between psychological factors and atopic disorders. 4 Further to this, several studies have investigated the association between anxiety or depression and adult asthma, 8, 9, [30] [31] [32] [33] [34] with relative risk estimates ranging from 1.24 to 2.80. Four of these were prospective studies, which found that anxiety or depression were associated with incident asthma. 8, 31, 33, 34 Our findings extend previous research by examining this hypothesis in a very large prospective cohort, with a comprehensive range of covariates to adjust for. Furthermore, our study investigated the joint association of anxiety or depression symptoms and obesity with incident asthma. We found that participants with anxiety or depression symptoms and also obesity had a greater risk of asthma than the sum of their individual risks, as indicated by the RERI.
The association between anxiety or depression symptoms and incident asthma may have biological plausibility. Two main pathways have been suggested, including changes in health behaviours and inflammatory processes. 34 Lifestyle-related behaviours such as smoking, and less physical exercise due to distress, may be mediators leading to the development of asthma. On the other hand, these health behaviour No HADS<8, yes HADS 58. b Incident asthma: no wheeze or asthma at baseline, reported asthma and asthma medication use at follow-up vs no wheeze or asthma at baseline or follow-up. c Adjusted for age, sex, smoking, physical activity, family history of asthma, education, social benefit and economic difficulties at baseline. d The relative excess risk due to interaction (RERI) between anxiety or depression symptoms (A) and obesity (B) was calculated using the formula: RERI ¼ OR AB À OR A À OR B þ 1. variables may also be confounding factors that cause both psychological distress and asthma. In any case, the attempt of adjustment for these factors (smoking and physical activity) in addition to the other covariates in our models did not substantially alter the association between anxiety or depression symptoms and incident asthma.
Our multivariable analysis suggests that inflammatory processes may be a potential pathway. Several studies have suggested that depression is linked to a state of low-grade chronic inflammation, 11 and anxiety has been associated with increased production of pro-inflammatory cytokines. 35 Furthermore, progression of psychological distress such as anxiety and depression may lead to irregular levels of circulating cortisol, and a glucocorticoid-insensitive state. [9] [10] [11] [12] Glucocorticoid receptor resistance has been observed in healthy adults exposed to long-term stressful experiences, parents of children with cancer and spouses of brain-cancer patients. 36 Consequently, the downregulation of glucocorticoid receptors may interfere with regulation of inflammation which may increase the risk of inflammatory disorders. 36 Miller et al. found that children with asthma and perceived low support from their parents (a proxy for stress) were more resistant to hydrocortisone's anti-inflammatory effects on pro-inflammatory cytokines, which shed some light on how stress affects asthma. 37 Therefore, a state of inflammation and glucocorticoid insensitivity due to chronic psychological distress might be the underlying pathophysiology for the association we observed.
Obesity is also a chronic inflammatory condition, 38 which will signal cortisol release through normal inflammatory signalling and the hypothalamic-pituitary-adrenal axis. 39 High levels of cortisol due to obesity may additionally contribute to cortisol insensitivity. 40 The further complication of obesity in anxious or depressed participants may worsen a common inflammatory pathway and, at least in part, explain the joint association that we observed. A reciprocal link between obesity and psychological distresses such as anxiety and depression has been reported in observational studies, [41] [42] [43] but further research is needed to investigate the underlying mechanism of this interaction. Our observation that participants with both anxiety or depression and obesity have an excess risk of asthma, suggests that a considerable number of asthma cases may be due to the presence of anxiety or depression and obesity in the same causal mechanism. Identifying people with anxiety or depression symptoms and obesity may make asthma prevention more effective. However, the study findings and their mechanistic implications merit further investigation.
Our study has several major strengths. The prospective study design indicates direction of the association. The size and duration of our study was an advantage to increase study power and the possibility of detecting associations. With the large study size we were able to assess the joint association of anxiety or depression symptoms and obesity with incident asthma, and also to address potential differences between sexes. The comprehensive data set allowed us to control for a range of potential confounding factors. Height and weight were objectively measured and recorded by nurses in standardized clinical examinations. This would have avoided subjective overreporting of height and under-reporting of weight. We also used another proxy measure for obesity (abdominal obesity) and found results similar to our original analysis. To strengthen our definition of anxiety or depression symptoms, we used an alternative definition adding those who used antidepressant medication into the symptom group, which minimized misclassification of exposure. The findings from these analyses supported our results.
With regard to potential limitations, we acknowledge that even though we controlled for many confounding factors there may still be residual confounding in our study. Another major challenge in epidemiological studies of asthma is the definition, since there is no gold standard for the diagnosis of asthma. Although we verified asthma cases by medication use, we cannot rule out possible misclassification bias since objective airway reversibility or hyper-responsiveness tests, were not performed. Also, misclassification of hyperventilation or shortness of breath as asthma in anxious participants cannot completely be ruled out as an explanation of our finding. However, self-reported asthma has been assessed as a reasonably robust method for population studies. 44, 45 To strengthen our diagnosis of asthma, we used a stricter definition of asthma verified by the use of asthma medication. Further to this, we excluded participants who reported chronic bronchitis, emphysema or COPD in the follow-up questionnaires to reduce possible misclassification of asthma and COPD. The results from all these additional analyses showed similar associations to our main findings.
In the current study, the HADS was used as a screening tool to capture symptoms of anxiety or depression. The ability of the HADS to separate clinical diagnoses of anxiety and depression disorders is uncertain, 46 and the HADS-identified cases may not have a close correspondence to clinical anxiety or depression. For example, we observed the lowest prevalence of anxiety or depression in the youngest group, who have been reported to have the highest prevalence of clinical mental disorders by others. 47, 48 We also observed a high prevalence of depression in men, which is greater than the prevalence from diagnoses based on interviews. 47, 48 The limitations of the HADS to identify clinical anxiety or depression may limit the generalizability of our results.
In summary, this large prospective cohort study suggests that anxiety or depression symptoms may contribute to the development of asthma and that obesity may interact with anxiety or depression symptoms to further increase the risk of asthma in adults. Further research is needed to confirm the presence of synergy between these two common risk factors and to explore the underlying mechanisms.
